Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03311555
Title A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Tian Zhang, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
GU Research Network / Urology Cancer Center Omaha Nebraska 68130 United States Details
Weill Cornell Medical Center New York New York 10065 United States Details
Duke Cancer Center Cary Cary North Carolina 27518 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Wake Forest Univesity Winston-Salem North Carolina 27157 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field